Menu
In a recent white paper, AmplifyBio examines the important considerations when designing and executing inhalation toxicology studies. In a built-for-purpose facility, AmplifyBio brings decades of experience and expertise to clients seeking critical safety data for inhaled test articles.
As an expert contract research organization (CRO), AmplifyBio leverages decades of experience to create modern commercial drug development solutions. From CRO and preclinical CRO needs to cell and gene therapy and advanced therapy testing, our accredited team designs innovative paths to produce globally recognized studies, services, and more.
